Search the Archive

Epilepsy / Sodium Valproate / FDA #490906

NBC Evening News for Friday, Oct 14, 1977
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio) Earlier report with regard to drug, sodium valproate used as treatment for certain type of epilepsy, noted; was available in Europe, but not in US. FDA (Food and Drug Administration) and Abbott Labs. have agreed to make it -available here.
REPORTER: David Brinkley

(Fredericksburg, Virginia) Update report on Jim and Anna Harley, brother and sister who are victims if myoclonic epilepsy, for which only treatment is sodium valproate. Process of FDA (Food and Drug Administration) in giving informal approval to manufacturer of drug is noted.
REPORTER: Bob Dotson

Brinkley, David;
Dotson, Bob

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.